Journal
NEUROBIOLOGY OF DISEASE
Volume 37, Issue 3, Pages 731-737Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2009.12.012
Keywords
Alzheimer disease; 8-Hydroxyguanosine; Intraneuronal amyloid-beta; Nucleic acids; Oligomer; Oxidative stress
Categories
Funding
- Japan Society for the Promotion of Science [20591387]
- National Institutes of Health [R01 AG026151]
- Alzheimer's Association [ZEN-07-59500]
- Grants-in-Aid for Scientific Research [20591387] Funding Source: KAKEN
Ask authors/readers for more resources
in an analysis of amyloid pathology in Alzheimer disease, we used an in situ approach to identify amyloid-beta (A beta) accumulation and oxidative damage to nucleic acids in postmortem brain tissue of the hippocampal formation from subjects with Alzheimer disease. When carboxyl-terminal-specific antibodies directed against A beta 40 and A beta 42 were used for immunocytochemical analyses, A beta 42 was especially apparent within the neuronal cytoplasm, at sites not detected by the antibody specific to A beta-oligomer. In comparison to the A beta 42-positive neurons, neurons bearing oxidative damage to nucleic acids were more widely distributed in the hippocampus. Comparative density measurements of the immunoreactivity revealed that levels of intraneuronal A beta 42 were inversely correlated with levels of intraneuronal 8-hydroxyguanosine, an oxidized nucleoside (r= -0.61, p<0.02). Together with recent evidence that the A beta peptide can act as an antioxidant, these results suggest that intraneuronal accumulation of non-oligomeric A beta may be a compensatory response in neurons to oxidative stress in Alzheimer disease. (C) 2009 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available